Cross Country Healthcare, Inc. (CCRN)
NASDAQ: CCRN · Real-Time Price · USD
13.11
+0.35 (2.70%)
Aug 13, 2025, 4:00 PM - Market closed
Cross Country Healthcare Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 1,193 | 1,344 | 2,020 | 2,803 | 1,677 | 836.42 | Upgrade
|
| Revenue Growth (YoY) | -24.30% | -33.46% | -27.95% | 67.20% | 100.46% | 1.73% | Upgrade
|
| Cost of Revenue | 951.73 | 1,070 | 1,569 | 2,179 | 1,302 | 633.69 | Upgrade
|
| Gross Profit | 240.81 | 274.25 | 450.41 | 624.46 | 375 | 202.73 | Upgrade
|
| Selling, General & Admin | 212.41 | 233.38 | 300.33 | 324.21 | 215.26 | 173.81 | Upgrade
|
| Other Operating Expenses | 1.97 | 1.97 | 0.03 | - | - | - | Upgrade
|
| Operating Expenses | 233.44 | 274.98 | 333.27 | 346.39 | 229.9 | 186.42 | Upgrade
|
| Operating Income | 7.38 | -0.73 | 117.14 | 278.06 | 145.1 | 16.32 | Upgrade
|
| Interest Expense | -2.25 | -2.19 | -8.09 | -14.39 | -6.87 | -2.89 | Upgrade
|
| Interest & Investment Income | 3.03 | 2.05 | 0.08 | 0.01 | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.51 | 0.61 | -0.09 | 1.33 | 0.77 | -0.28 | Upgrade
|
| EBT Excluding Unusual Items | 7.64 | -0.26 | 109.05 | 265.01 | 139.01 | 13.15 | Upgrade
|
| Merger & Restructuring Charges | -13.7 | -8.55 | -3.33 | -2.59 | -3.73 | -6.13 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -10.2 | Upgrade
|
| Asset Writedown | -2.89 | -2.89 | - | -5.6 | -2.07 | -9.15 | Upgrade
|
| Legal Settlements | 1.8 | -4.7 | -1.1 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | -1.72 | -3.73 | - | - | Upgrade
|
| Pretax Income | -7.15 | -16.4 | 102.89 | 253.1 | 133.21 | -12.33 | Upgrade
|
| Income Tax Expense | 1.19 | -1.84 | 30.26 | 67.12 | 1.21 | -0.19 | Upgrade
|
| Earnings From Continuing Operations | -8.35 | -14.56 | 72.63 | 185.98 | 132 | -12.14 | Upgrade
|
| Minority Interest in Earnings | - | - | - | - | - | -0.82 | Upgrade
|
| Net Income | -8.35 | -14.56 | 72.63 | 185.98 | 132 | -12.96 | Upgrade
|
| Net Income to Common | -8.35 | -14.56 | 72.63 | 185.98 | 132 | -12.96 | Upgrade
|
| Net Income Growth | - | - | -60.95% | 40.89% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 33 | 33 | 35 | 37 | 37 | 36 | Upgrade
|
| Shares Outstanding (Diluted) | 33 | 33 | 35 | 38 | 37 | 36 | Upgrade
|
| Shares Change (YoY) | -5.71% | -5.91% | -5.49% | 0.39% | 3.61% | 0.76% | Upgrade
|
| EPS (Basic) | -0.26 | -0.44 | 2.07 | 5.02 | 3.60 | -0.36 | Upgrade
|
| EPS (Diluted) | -0.26 | -0.44 | 2.05 | 4.95 | 3.53 | -0.36 | Upgrade
|
| EPS Growth | - | - | -58.59% | 40.23% | - | - | Upgrade
|
| Free Cash Flow | 34.09 | 111.4 | 234.52 | 125.26 | -92.79 | 22.59 | Upgrade
|
| Free Cash Flow Per Share | 1.05 | 3.34 | 6.61 | 3.34 | -2.48 | 0.63 | Upgrade
|
| Gross Margin | 20.19% | 20.41% | 22.30% | 22.27% | 22.37% | 24.24% | Upgrade
|
| Operating Margin | 0.62% | -0.05% | 5.80% | 9.92% | 8.65% | 1.95% | Upgrade
|
| Profit Margin | -0.70% | -1.08% | 3.60% | 6.63% | 7.87% | -1.55% | Upgrade
|
| Free Cash Flow Margin | 2.86% | 8.29% | 11.61% | 4.47% | -5.53% | 2.70% | Upgrade
|
| EBITDA | 24.39 | 16.78 | 134.99 | 290.04 | 154.56 | 25.89 | Upgrade
|
| EBITDA Margin | 2.04% | 1.25% | 6.68% | 10.35% | 9.22% | 3.09% | Upgrade
|
| D&A For EBITDA | 17.01 | 17.5 | 17.85 | 11.98 | 9.45 | 9.57 | Upgrade
|
| EBIT | 7.38 | -0.73 | 117.14 | 278.06 | 145.1 | 16.32 | Upgrade
|
| EBIT Margin | 0.62% | -0.05% | 5.80% | 9.92% | 8.65% | 1.95% | Upgrade
|
| Effective Tax Rate | - | - | 29.41% | 26.52% | 0.91% | - | Upgrade
|
| Advertising Expenses | - | 8.5 | 11.5 | 16.1 | 9.5 | 6.2 | Upgrade
|
Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.